Tuesday, November 5, 2024
HomeTagsNon-Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics